Dynamic detection of anti-HLA antibodies can predict graft-versus-host disease and overall survival in HLA 12/12–matched unrelated donor hematopoietic stem cell transplantation for hematological malignancies, especially for acute myeloid leukemia/myelodysplastic syndromes
Routine monitoring for anti-HLA antibody dynamics should be conducted before and after hematopoietic stem cell transplantation
Anti-HLA antibodies independently predicted for negative outcome of hematopoietic stem cell transplantation independent of HLA-DP loci mismatches. HLA-DP loci mismatches were associated with poor prognosis in the anti-HLA Abs-negative group
For the first time, we reported the impact of anti-HLA antibodies and HLA-DP loci mismatches on hematopoietic stem cell transplantation outcomes in HLA 12/12–matched unrelated donor hematopoietic stem cell transplantation